| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0073 | 1 |